Terms: = Uterine cancer AND MED12, Q93074, TRAP230, TNRC11, OKS, KIAA0192, HOPA, FGS1, CAGH45, ARC240, 9968
150 results:
1. Racial disparity in uterine leiomyoma: new insights of genetic and environmental burden in myometrial cells.
Khan NH; McNally R; Kim JJ; Wei JJ
Mol Hum Reprod; 2024 Feb; 30(3):. PubMed ID: 38290796
[TBL] [Abstract] [Full Text] [Related]
2. The Effect of Race/Ethnicity and med12 Mutation on the Expression of Long Non-Coding RNAs in uterine Leiomyoma and Myometrium.
Chuang TD; Ton N; Rysling S; Boos D; Khorram O
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38279317
[TBL] [Abstract] [Full Text] [Related]
3. Establishment of Noninvasive Prediction Models for the Diagnosis of uterine Leiomyoma Subtypes.
Tamehisa T; Sato S; Sakai T; Maekawa R; Tanabe M; Ito K; Sugino N
Obstet Gynecol; 2024 Mar; 143(3):358-365. PubMed ID: 38061038
[TBL] [Abstract] [Full Text] [Related]
4. RISING STARS: Role of med12 mutation in the pathogenesis of uterine fibroids.
Ishikawa H; Kobayashi T; Kaneko M; Saito Y; Shozu M; Koga K
J Mol Endocrinol; 2023 Nov; 71(4):. PubMed ID: 37668348
[TBL] [Abstract] [Full Text] [Related]
5. med12 mutation activates the tryptophan/kynurenine/AHR pathway to promote growth of uterine leiomyomas.
Zuberi A; Huang Y; Dotts AJ; Wei H; Coon JS; Liu S; Iizuka T; Wu O; Sotos O; Saini P; Chakravarti D; Boyer TG; Dai Y; Bulun SE; Yin P
JCI Insight; 2023 Sep; 8(18):. PubMed ID: 37607000
[TBL] [Abstract] [Full Text] [Related]
6. The Mediator Complex Subunit 12 (MED-12) Gene and uterine Fibroids: a Systematic Review.
Amendola ILS; Spann M; Segars J; Singh B
Reprod Sci; 2024 Feb; 31(2):291-308. PubMed ID: 37516697
[TBL] [Abstract] [Full Text] [Related]
7. Engineered med12 mutations drive leiomyoma-like transcriptional and metabolic programs by altering the 3D genome compartmentalization.
Buyukcelebi K; Chen X; Abdula F; Elkafas H; Duval AJ; Ozturk H; Seker-Polat F; Jin Q; Yin P; Feng Y; Bulun SE; Wei JJ; Yue F; Adli M
Nat Commun; 2023 Jul; 14(1):4057. PubMed ID: 37429859
[TBL] [Abstract] [Full Text] [Related]
8. A View on uterine Leiomyoma Genesis through the Prism of Genetic, Epigenetic and Cellular Heterogeneity.
Koltsova AS; Efimova OA; Pendina AA
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982825
[TBL] [Abstract] [Full Text] [Related]
9. Differential Expression of med12-Associated Coding RNA Transcripts in uterine Leiomyomas.
Chuang TD; Gao J; Quintanilla D; McSwiggin H; Boos D; Yan W; Khorram O
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835153
[TBL] [Abstract] [Full Text] [Related]
10. High-Grade Sarcomas with Myogenic Differentiation Harboring Hotspot PDGFRB Mutations.
Dermawan JK; Chiang S; Hensley ML; Tap WD; Antonescu CR
Mod Pathol; 2023 May; 36(5):100104. PubMed ID: 36788091
[TBL] [Abstract] [Full Text] [Related]
11. Inherited mutations affecting the SRCAP complex are central in moderate-penetrance predisposition to uterine leiomyomas.
Välimäki N; Jokinen V; Cajuso T; Kuisma H; Taira A; Dagnaud O; Ilves S; Kaukomaa J; Pasanen A; Palin K; Heikinheimo O; Bützow R; Aaltonen LA; Karhu A
Am J Hum Genet; 2023 Mar; 110(3):460-474. PubMed ID: 36773604
[TBL] [Abstract] [Full Text] [Related]
12. Racial differences in transcriptomics and reactive oxygen species burden in myometrium and leiomyoma.
Li Y; McNally RP; Feng Y; Kim JJ; Wei JJ
Hum Reprod; 2023 Apr; 38(4):609-620. PubMed ID: 36749068
[TBL] [Abstract] [Full Text] [Related]
13. med12 mutations in uterine leiomyomas: prediction of volume reduction by gonadotropin-releasing hormone agonists.
Nagai K; Asano R; Sekiguchi F; Asai-Sato M; Miyagi Y; Miyagi E
Am J Obstet Gynecol; 2023 Feb; 228(2):207.e1-207.e9. PubMed ID: 36150519
[TBL] [Abstract] [Full Text] [Related]
14. Molecular subclass of uterine fibroids predicts tumor shrinkage in response to ulipristal acetate.
Kolterud Å; Välimäki N; Kuisma H; Patomo J; Ilves ST; Mäkinen N; Kaukomaa J; Palin K; Kaasinen E; Karhu A; Pasanen A; Bützow R; Heikinheimo O; Kopp Kallner H; Aaltonen LA
Hum Mol Genet; 2023 Mar; 32(7):1063-1071. PubMed ID: 36048862
[TBL] [Abstract] [Full Text] [Related]
15. Single-cell sequencing reveals novel cellular heterogeneity in uterine leiomyomas.
Goad J; Rudolph J; Zandigohar M; Tae M; Dai Y; Wei JJ; Bulun SE; Chakravarti D; Rajkovic A
Hum Reprod; 2022 Sep; 37(10):2334-2349. PubMed ID: 36001050
[TBL] [Abstract] [Full Text] [Related]
16. Histological and molecular analysis of cellular leiomyoma with sclerosis: linked to HMGA2 overexpression.
Griffin BB; Feng Y; Saini P; Lu X; Bulun S; Chakravarti D; Wei JJ
Histopathology; 2022 Nov; 81(5):587-599. PubMed ID: 35961656
[TBL] [Abstract] [Full Text] [Related]
17. An Unusual Benign uterine Stromal Spindle Cell Tumor Harboring JAZF1::BCORL1.
Rodriguez Pena MDC; Mubeen A; Harada S; Prieto Granada CN
Int J Gynecol Pathol; 2023 May; 42(3):319-324. PubMed ID: 35838627
[TBL] [Abstract] [Full Text] [Related]
18. 3'RNA and whole-genome sequencing of archival uterine leiomyomas reveal a tumor subtype with chromosomal rearrangements affecting either HMGA2, HMGA1, or PLAG1.
Jokinen V; Mehine M; Reinikka S; Khamaiseh S; Ahvenainen T; Äyräväinen A; Härkki P; Bützow R; Pasanen A; Vahteristo P
Genes Chromosomes Cancer; 2023 Jan; 62(1):27-38. PubMed ID: 35822448
[TBL] [Abstract] [Full Text] [Related]
19. A mediator complex subunit 12 gain-of-function mutation induces partial leiomyoma cell properties in human uterine smooth muscle cells.
Takao T; Ono M; Yoshimasa Y; Masuda H; Maruyama T
F S Sci; 2022 Aug; 3(3):288-298. PubMed ID: 35643626
[TBL] [Abstract] [Full Text] [Related]
20. Cyclin-dependent kinase 8 is an independent prognosticator in uterine leiomyosarcoma.
Yasutake N; Iwasaki T; Yamamoto H; Sonoda K; Kodama K; Okugawa K; Asanoma K; Yahata H; Kato K; Oda Y
Pathol Res Pract; 2022 Jul; 235():153920. PubMed ID: 35605413
[TBL] [Abstract] [Full Text] [Related]
[Next]
